Article Information
History
- December 14, 2024.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- aHealth Economics and Epidemiology Research Office, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
- bDepartment of Global Health and Development, London School of Hygiene and Tropical Medicine, London, United Kingdom
- cDepartment of Global Health, Boston University School of Public Health, Boston, Massachusetts, USA
- dDepartment of Global Health, Amsterdam Institute for Global Health and Development, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands
- eSouth African Department of Science and Innovation/National Research Foundation Centre of Excellence in Epidemiological Modelling and Analysis (SACEMA), Stellenbosch University, Stellenbosch, South Africa
- ↵#Corresponding author
: Nkgomeleng Lekodeba; Health Economics and Epidemiology Research Office, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa. Building C, First Floor, Sunnyside Office Park, 32 Princess of Wales Terrace, Parktown, Johannesburg, 2193. nlekodeba{at}heroza.org, Tell: +2710 001 7930
↵* Contributed equally to this paper
Posted December 14, 2024.
Cost and cost-effectiveness analysis of near point-of-care GeneXpert testing for STIs in South Africa: leveraging current capacity to address high prevalence of Chlamydia trachomatis, Neisseria gonorrhoeae and Trichomonas vaginalis
